Company news

Kodiak Sciences Inc news in 2024

Kodiak Sciences Inc's news releases, calls and decks from 2024, newest first.

View company

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results

November 13, 2024

Kodiak Sciences to Participate in Upcoming Investor Conferences

November 10, 2024

Kodiak Sciences to Present at Innovate Retina 2024

October 13, 2024

Kodiak Sciences to Host Investor R&D Day Today at 10: 30am Eastern Time

September 22, 2024

Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City

September 16, 2024

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results

August 13, 2024

Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences

May 28, 2024

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results

May 14, 2024

Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

May 12, 2024

Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform

May 1, 2024

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

March 27, 2024

Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024

March 25, 2024

Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting

January 29, 2024

Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 3, 2024

Decks in 2024